Effect of Baseline MTX Dose on Clinical Efficacy and Safety in Rheumatoid Arthritis Patients Treated with Filgotinib: Post-Hoc Analysis from a Phase 2B Study

被引：0
|
作者：
Westhovens, Rene [1 ]
van der Aa, Annegret [2 ]
Jamoul, Corinne [2 ]
Tasset, Chantal [2 ]
Harrison, Pille [2 ]
机构：
[1] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Leuven, Belgium
[2] Galapagos NV, Mechelen, Belgium
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
GLPG0634/GS-6034; INHIBITOR;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
534
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
    Shimizu, Hirohito
    Kobayashi, Hisanori
    Kanbori, Masayoshi
    Ishii, Yutaka
    RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 311 - 325
  • [32] Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
    Hirohito Shimizu
    Hisanori Kobayashi
    Masayoshi Kanbori
    Yutaka Ishii
    Rheumatology and Therapy, 2020, 7 : 311 - 325
  • [33] Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis
    Yoshiya Tanaka
    Nobuko Horiuchi
    Cosmo Sasajima
    Rumiko Matsumoto
    Masafumi Kawanishi
    Saeko Uchida
    Tsutomu Takeuchi
    Rheumatology and Therapy, 2025, 12 (2) : 283 - 296
  • [34] Efficacy and Safety of Upadacitinib in Patients Across Races with Rheumatoid Arthritis: A Post Hoc Analysis of Six Phase 3 Clinical Trials
    Wright, Grace
    Mysler, Eduardo
    Navarro-Millan, Iris
    Tanaka, Yoshiya
    Anyanwu, Samuel
    Liu, Jianzhong
    Tanjinatus, Oishi
    Garrison, Andrew
    Wells, Alvin
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 548 - 550
  • [35] POST-HOC ANALYSIS FROM A PHASE III TRIAL ASSESSING THE SAFETY AND EFFICACY OF RIX-FP IN PREVIOUSLY TREATED ADOLESCENT PATIENTS WITH HAEMOPHILIA B
    Alvarez Roman, M. T.
    Drelich, D. A.
    Seifert, W.
    Castaman, G.
    HAEMOPHILIA, 2023, 29 : 41 - 42
  • [36] Impact of atacicept on hematuria in IGA nephropathy: post-hoc analysis of the phase 2b ORIGIN study
    Floege, Juergen
    Barratt, Jonathan
    Maes, Bart
    Cooper, Kerry
    Lin, Celia
    Wei, Xuelian
    Barbour, Sean
    Phoon, Richard
    Kim, Sung Gyun
    Tesar, Vladimir
    Jha, Vivekanand
    Wadhwani, Shikha
    Lafayette, Richard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I710 - I711
  • [37] Baseline disease severity of patients with Ulcerative Colitis influences rapid symptom relief under filgotinib treatment: post hoc analysis of the phase 2b/3 SELECTION study
    Saruta, M.
    Danese, S.
    Takatori, Y.
    Kaise, T.
    Rudolph, C.
    Ferrante, M.
    Hibi, T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1506 - I1507
  • [38] Predictors of Placebo Response in Patients With Irritable Bowel Syndrome and Constipation: A Post-Hoc Analysis From Pooled Phase 2b/3 Studies Assessing the Safety and Efficacy of Linaclotide
    Nee, Judy
    Kelley, John
    Ballou, Sarah
    Almansa, Cristina
    Kosch, Katherine J.
    Wu, James
    Lembo, Anthony
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S370 - S370
  • [39] Efficacy and Safety of Sarilumab Plus MTX in Subgroups of Patients with Rheumatoid Arthritis in a Phase 3 Study
    Kavanaugh, Arthur
    Kivitz, Alan J.
    Miranda, P.
    Fiore, Stefano
    Fay, Jonathan
    Fan, Chunpeng
    van Adelsberg, Janet
    Huizinga, T. W. J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [40] EFFICACY AND SAFETY OF SARILUMAB PLUS MTX IN SUBGROUPS OF PATIENTS WITH RHEUMATOID ARTHRITIS IN A PHASE 3 STUDY
    Kavanaugh, Arthur
    Kivitz, Alan J.
    Miranda, Pedro C.
    Fiore, Stefano
    Fay, Jonathan
    Fan, Chunpeng
    Van Adelsberg, Janet
    Huizinga, Tom W. J.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 42 - 42
12345